生脉联合地塞米松治疗放射性肺炎的临床观察  

Shengmai plus Dexamethasone in the Treatment of Radiation Pneumonia

作　　者：徐惠[1] 王承伟[1] 吴立广[1] 冯志俊[1] 

机构地区：[1]江苏大学附属人民医院,江苏镇江212002

出　　处：《肿瘤基础与临床》2015年第2期141-143,共3页journal of basic and clinical oncology

摘　　要：目的评价生脉联合地塞米松治疗放射性肺炎的疗效。方法 30例确诊的放射性肺炎患者给予生脉和地塞米松。结果 30例均可评价疗效,其中显效12例(40.0%),有效15例(50.0%),无效3例(10.0%),总有效率为90.0%。结论生脉联合地塞米松治疗放射性肺炎安全有效。Objective To evaluate the effect of shengmai plus dexamethasone in the treatment of radiation pneu- monia. Methods Thirty patients with radiation pneumonia were treated with shengmai plus dexamethasone. Results All the 30 patients could be evaluated,the marked effect was observed in the 12 patients （40.0%） ,the effect in the 15 patients （50.0%） ,no effect in the 3 patients （10.0%） ,the total effective rate was 90.0%. Conclusion Shengmai plus dexamethasone is effect and safe in the treatment of radiation pneumonia.

关 键 词：生脉 放疗 放射性肺炎 

分 类 号：R730.55[医药卫生—肿瘤] R730.6[医药卫生—临床医学]